ReutersT-cell cancer therapy holds promise, longer-term results awaitReutersThe new drug class, known as chimeric antigen receptor T-cell or CAR-T, involves a complicated process of extracting immune system T-cells from an individual patient, altering … Continue reading
|
Immunotherapy Drugs Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025
Medgadget (blog) Immunotherapy is the management of a disease by enhancing, suppressing, or inducing an immune response. Some immunotherapies are designed to magnify or elicit an immune response. They are known as activation immunotherapies. However, some … |
Chicago Daily Herald |
Novel leukemia treatment could be 1st US gene therapy
Chicago Daily Herald CAR-T therapy starts with filtering key immune cells called T cells from a patient’s blood. In a lab, a gene is then inserted into the T cells that prompts them to grow a receptor that targets a special marker found on some blood cancer cells. Millions … |
Chicago Daily Herald |
Novel leukemia treatment could be 1st US gene therapy
Chicago Daily Herald CAR-T therapy starts with filtering key immune cells called T cells from a patient’s blood. In a lab, a gene is then inserted into the T cells that prompts them to grow a receptor that targets a special marker found on some blood cancer cells. Millions … |
USA TODAY |
‘Major advance’: Leukemia treatment could be first US gene therapy
USA TODAY A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S.. A Food and Drug Administration advisory panel voted 10-0 on Wednesday in favor of the leukemia treatment developed by the University of … Gene therapy to kill cancer moves a step closer to marketCNET Pioneering cancer gene therapy by Novartis backed by US panelCNBC Novel leukemia treatment could be 1st US gene therapyABC News CBS News –Reuters –Sun Sentinel –FDA all 101 news articles » |